Article ; Online: Understanding the Cellular Sources of the Fractional Exhaled Nitric Oxide (FeNO) and Its Role as a Biomarker of Type 2 Inflammation in Asthma.
2022 Volume 2022, Page(s) 5753524
Abstract: Fractional exhaled nitric oxide (FeNO) has gained great clinical importance as a biomarker of type 2 inflammation in chronic airway diseases such as asthma. FeNO originates primarily in the bronchial epithelium and is produced in large quantities by the ... ...
Abstract | Fractional exhaled nitric oxide (FeNO) has gained great clinical importance as a biomarker of type 2 inflammation in chronic airway diseases such as asthma. FeNO originates primarily in the bronchial epithelium and is produced in large quantities by the enzyme inducible nitric oxide synthase (iNOS). It should be noted that nitric oxide (NO) produced at femtomolar to picomolar levels is fundamental for respiratory physiology. This basal production is induced in the bronchial epithelium by interferon gamma (IFN |
---|---|
MeSH term(s) | Asthma/drug therapy ; Biomarkers/metabolism ; Breath Tests ; Exhalation ; Fractional Exhaled Nitric Oxide Testing ; Humans ; Inflammation ; Nitric Oxide/metabolism |
Chemical Substances | Biomarkers ; Nitric Oxide (31C4KY9ESH) |
Language | English |
Publishing date | 2022-05-02 |
Publishing country | United States |
Document type | Journal Article ; Review |
ZDB-ID | 2698540-8 |
ISSN | 2314-6141 ; 2314-6133 |
ISSN (online) | 2314-6141 |
ISSN | 2314-6133 |
DOI | 10.1155/2022/5753524 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.